MRK
Merck & Co. Inc.
NYSE
Healthcare
$145.95
+0.87
(+0.60%)
Updated: 10/16/2026, 8:55:00 PM
Open
$146.96
High
$147.70
Low
$144.58
Prev Close
$145.19
Volume
7.34M
Price History
Why Is MRK ▲ Up Today?
+0.60%
Full AI analysis generates after market close. Showing live price data.
Oct 16
▲
+0.6%
Merck Posts Modest Gain, Outperforming Sector Average
Oct 15
▼
-2.2%
Merck (MRK) underperforms sector with a 2.16% decline
Oct 14
▲
+4.0%
Merck shares climb on investor optimism ahead of Q3 earnings
Oct 13
▼
-2.4%
Merck declines, underperforming a downbeat healthcare sector
Oct 12
▼
-0.3%
Merck Dips Slightly Amid Keytruda Legal Setback in Europe
Oct 9
▲
+2.3%
Merck Shares Rise, Outperforming Sector Average
Oct 8
▼
-0.6%
Merck Dips Slightly Amidst Keytruda SC European Block
Oct 7
▲
+0.5%
Merck Posts Modest Gain, Trails Pharmaceutical Sector's Stronger Advance
Oct 6
▲
+1.8%
Merck Rises on Positive Tulisokibart Clinical Trial Results
Oct 5
▼
-3.2%
Merck Shares Fall Sharply Despite Positive Clinical Trial News
Oct 2
▲
+0.1%
Merck Sees Modest Gains Following Positive Clinical Trial Results
Oct 1
▼
-1.0%
Merck (MRK) Dips More Than Sector Average Amid Market Weakness
Sep 30
▼
-2.4%
Merck shares fall, underperforming broader healthcare sector
Sep 29
▲
+0.4%
Merck (MRK) Posts Modest Gain, Outperforms Sector
Sep 28
—
-0.1%
Merck (MRK) experiences minor dip, underperforms sector
Sep 25
▲
+0.1%
Merck Posts Modest Gain Amidst General Market Movement
Sep 24
—
-0.0%
Merck (MRK) sees minimal dip, underperforming positive sector
Sep 23
▼
-1.9%
Merck (MRK) Shares Decline 1.88%, Underperforming Sector
Sep 22
▲
+1.3%
Merck (MRK) Shares Climb Amid Positive Analyst Sentiment
Sep 21
▲
+1.9%
Merck & Co. Shares Climb, Outpacing Sector Average
Sep 18
▼
-0.3%
Merck sees slight dip, underperforming sector's modest gains
Sep 17
▲
+1.6%
MRK Gains on Pipeline Strength, Outperforms Sector
Sep 16
▲
+0.8%
Merck Outperforms Sector on Optimism for Growing Pipeline and New Drugs
Sep 15
▼
-0.7%
Merck Dips Slightly, Underperforming Sector Amidst Pipeline Focus
Sep 14
▲
+0.4%
Merck Edges Higher on Pipeline Hopes and Analyst Reports
Sep 11
▼
-0.7%
Merck Dips Slightly, Underperforming Broader Pharmaceutical Sector
Sep 10
▼
-1.9%
Merck Shares Fall, Significantly Underperforming Pharmaceutical Sector
Sep 9
▼
-0.6%
Merck experiences modest decline, underperforming sector average
Sep 8
▼
-0.4%
Merck (MRK) Dips Modestly, Outperforming Broader Sector Downturn
Sep 7
—
+0.0%
Merck (MRK) Closes Flat with No Trading Activity
Financial Highlights
Income Statement
Revenue
$64.23B
Gross Profit
$49.58B
77.2% margin
Operating Income
$21.82B
34.0% margin
Net Income
$19.04B
29.6% margin
EPS (Diluted)
$7.57
R&D Spend
$16.49B
Balance Sheet
Total Assets
$129.55B
Total Liabilities
$77.64B
Stockholders' Equity
$51.91B
Cash Flow
Operating Cash Flow
$17.07B
Investing Activities
-$3.98B
Net Cash Flow
$3.57B
Highly Regarded Analysis for MRK
Get a deep-dive analysis including bull/bear cases, technical outlook, price targets, and key catalysts — powered by Highly Regarded's proprietary analysis engine.
Usually takes 10-20 seconds
Analyzing MRK...
Searching financial data and generating insights
Analysis couldn't be generated
Go Deeper on MRK
Key Stats
P/E Ratio
19.3x
EPS (Diluted)
$7.57
Gross Margin
77.2%
Operating Margin
34.0%
Net Margin
29.6%
Revenue (Qtr)
$64.23B
Shares Outstanding
2.48B
Next Earnings
Date
Oct 29, 2026
Time
Before Open
Quarter
Q3 2026
EPS Estimate
$2.12
MRK News
No recent news for MRK.
